期刊文献+

利用肠激酶加工融合蛋白的方法制备rhIL-11 被引量:3

Preparation of rhIL-11 from Fusion Protein by Using Enterokinase
下载PDF
导出
摘要 本研究探讨利用肠激酶加工融合蛋白的方法制备重组人白细胞介素11(rhIL-11)的工艺条件与参数。融合表达载体pET32a/IL-11在大肠杆菌E.coliBL21(DE3)pLysS中诱导表达,裂解上清以Ni-NTA亲和纯化,通过DsbA-EKL-(His)8的自催化切割完成单体活性肠激酶催化亚基的释放,继而对Trx-IL-11行使酶促切割作用制备rhIL-11。结果表明:亲和纯化得重组融合蛋白Trx-IL-11 11.25 mg/g湿菌,产品纯度达89.2%,回收率为91.8%。酶切体系经Ni-NTA resin充分吸附后,目标产品单体rhIL-11纯度大于95%。结论:利用肠激酶加工融合蛋白以制备rhIL-11的方法简单可行,分离纯化效果好,能够满足工业生产的需要。 The study was aimed to investigate the technological parameters of rhIL-11 preparation from fusion protein by using enterokinase. Fusion expression vector pET32a/IL-11 was transferred into E. coli BL21 (DE3)pLysS and its expression was induced by IPTG, the lysis supernatant of the engineering strain was purified by Ni-NTA resin and then the target rhIL-11 was digested by auto-cleavaged DsbA-EKL-(His)8. The results showed that after affinity chromatography, Trx-IL-11 was obtained with the yield of 11.25mg/g, the purity of 89.2% and the recovery of 91.8%. Finally the target rhIL-11 was digested and purified to over 95%. In conclusion, the preparation method of rhIL-11 from fusion protein by using enterokinase is simple and feasible with good separation, which can meet industrial requirements.
作者 赵阳 黄鹤
出处 《中国实验血液学杂志》 CAS CSCD 2008年第4期903-909,共7页 Journal of Experimental Hematology
基金 天津市自然科学基金资助项目 编号06YFJMJ-C013200
关键词 白介素11 肠激酶 融合蛋白 亲和纯化 IL-11 enterokinase fusion protein affinity purification
  • 相关文献

参考文献3

二级参考文献28

  • 1[1]Johan E,Peter A E. CBP is required for sterol-regulated and sterol regulatory element binding protein-regulated transcrip tion[J]. J Biol Chem, 1998,273:17865~ 17870.
  • 2[2]Nilsson J,Nilsson P,Williams Y,Pettersson L,Uhlen M,Nygren P A. Competitive elution of protein A fusions allows specific recovery under mild conditions[J]. Eur J Biochem,1994,224: 103~108.
  • 3[3]Kitamoto Y,Yuan X,Wu Q,McCourt D W,Sadler J E. Entero kinase,the initiator of intestinal digestion,is a mosaic protease composed of a distinctive assortment of domains[J]. Proc Natl Acad Sci USA, 1994,91 : 7588~7592.
  • 4[4]Sambrook J,Fritsch E F,Maniatis T. Molecularcloning: Alab oratorymanual[M]. 2nded NY: Cold Spring Harbor Laborato ry Press, 1989.
  • 5[7]Kitamoto Y,Veile R A,Donis-Keller H,Sadler J E. cDNA se quence and chromosomal localization of human enterokinase, the proteolytic activator of trypsinogen [J]. Biochemistry, 1995,34: 4562~4568.
  • 6[8]Collins-Racie L A,McColgan J M,Grant K L,DiBlasio-Smith E A,McCoy J M, LaVallie E R. Production of recombinant bo vine enterokinase catalytic subunit in Escherichia coli using the novel secretory fusion partner DsbA[J]. Biotechnology, 1995, 13: 982~987.
  • 7[10]LaVallie E R,Rehemtulla A,Racie L A,DiBlasio E A,Ferenz C,Grant K L,Light A,McCoy J M. Cloning and functional ex pression of a cDNA encoding the catalytic subunit of bovine en terokinase[J]. J Biol Chem, 1993,268: 23311 ~ 23317.
  • 8[11]Fonseca P, Light A. The purification and characterization of bovine enterokinase from membrane fragments in the duodenal mucosal fluid[J]. J Biol Chem,1983,258: 14516~14520.
  • 9[12]Vozza L A,Wittwer L,Higgins D R,Purcell T J,Bergseid M, Collins-Racie L A, Lavallie E R, Hoeffler J P. Production of a recombinant bovine enterokinase catalytic subunit in the meth ylotrophic yeast Pichia pastoris [J ]. Biotechnology, 1996, 14: 77~81.
  • 10[13]Yuan L D, Hua Z C. Expression, purification, and characterization of a biologically active bovine enterokinase catalytic subunit in Escherichia coli[J]. Protein Expr Purif,2002,25: 300~304.

共引文献14

同被引文献33

  • 1常艺海,丛丽娜,卢冬.重组海参溶菌酶基因工程菌的构建及原核表达[J].大连工业大学学报,2012,31(6):391-394. 被引量:5
  • 2刘兴敏,何自福,李华平,虞皓.溶菌酶基因合成及其原核表达[J].华南农业大学学报,2007,28(1):55-57. 被引量:1
  • 3易进华,王罗春,张元兴.重组肠激酶酶切Trx-rPA融合蛋白的研究[J].中国医药工业杂志,2007,38(6):419-422. 被引量:3
  • 4PAUL S R, BENNETT F, CALVETTI J A, et al. Molecular cloning of a eDNA encoding interleukln 11, a stromal cell- derived lymphopoietie and hematopoietic cytokine[J]. Proc Natl Acad Sci USA, 1990, 87(19): 7512-7516.
  • 5TERAMURA M, KOBAYASHI S, HOSHINO S, et al. Interleukin-11 enhances human megakaryocytopoiesis in vitro [J]. Blood, 1992, 79(2): 327-331.
  • 6YONEMURA Y, KAWAKITA M, MASUDA T, et al. Effect of recombinant human interleukin-ll on rat megakaryopoiesis and thrombopoiesis in viva: comparative study with interleukin-6 [J]. Br J Haematol, 1993, 84 (1) :16-23.
  • 7KELLER D C, DU X X, SROUR E F, et al. Interleukin-ll inhibits adipogenesis and stimulates myeiopoiesis in human long-term marrow cultures[J]. Blood, 1993, 82(5) : 1428- 1435.
  • 8HIRAYAMA F, KATAYAMA N, NEBEN S, et al. Synergistic interaction between interleukin-12 and steel factor in support of proliferation of murine lymphohematopoietic progenitors in culture[J]. Blood, 1994, 83(1): 92-98.
  • 9DU X, WILLIAMS D A. Update on development of interleukin-11[J]. Curr Opin Hematol, 1995, 2(3) : 182-188.
  • 10SANDS B E, WINSTON B D, SALZBERG B, et al. Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease[J]. Aliment Pharmacol Ther, 2002, 16(3): 399-406.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部